Health Condition 1: L305- Pityriasis alba
Conditions
Interventions
Intervention1: Habb-e-Kalaf: 1 Pill (250mg) twice daily locally after mixing the pills with lemon juice for 2 weeks
Intervention2: Habb-e-Kalaf: 1 Pill (250mg) twice daily locally after mixing the pil
Sponsors
Central Council for Research in Unani Medicine (CCRUM), New Delhi
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients of either sex in the age group of 13-60 years. 2. Patients of both genders. 3. Clinically diagnosed patients of Bahaq (Pityriasis). Hypo pigmented or hyper pigmented macules and patches. Scaling Itching Erythema 4. Clinically stable patients.
Exclusion criteria
Exclusion criteria: 1. Age 60 years. 2. Patients with other inflammatory skin conditions like localized abscess/ carbuncles/ boils etc. 3. Patients with other skin conditions like Eczema/ Vitiligo/ Psoriasis etc. 4. Patient with critical health condition like uncontrolled Diabetes Mellitus, Severe Hepatic and Renal diseases. 5. Patients who are not willing to participate in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Efficacy will be assessed on the basis of clinical parameters i.e. Hypo pigmented lesions/ Macules (Flat , distinct, colored area of the skin less than 1 cm in diameter), Hyper pigmented lesions/ Macules (Flat , distinct, colored area of the skin less than 1 cm in diameter), Erythema, Pruritus, ScalingTimepoint: At baseline, 7th and 14th day | — |
Secondary
| Measure | Time frame |
|---|---|
| Haematological and biochemical assessment for safety assessmentTimepoint: At baseline and 14th day | — |
Countries
India
Contacts
Public ContactDr Pradeep Kumar
Central Council for Research in Unani Medicine (CCRUM)
Outcome results
None listed